To address whether inhibiting ALK, ATR or a combination of both would affect cell proliferation and cell death, ALK-addicted NB cells were treated either with ALK inhibitors (crizotinib or lorlatinib) and/or BAY 1895344. The gene discussed is ALK; the disease is neuroblastoma.